TTF-1 and c-MYC-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for Treatment Selection

The standard treatment regimen has not yet been established for advanced pulmonary large cell neuroendocrine carcinoma (LCNEC) because of its rarity. LCNEC can be subdivided into 2 mutually exclusive molecular subgroups: STK11/KEAP1 and TP53 mutated with high neuroendocrine expression and transcript...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyagawa-Hayashino, Aya, Okada, Satoru, Takeda-Miyata, Naoko, Takashima, Yasutoshi, Yamada, Tadaaki, Takemura, Yoshizumi, Uchino, Junji, Inoue, Masayoshi, Takayama, Koichi, Konishi, Eiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132912/
https://www.ncbi.nlm.nih.gov/pubmed/33031101
http://dx.doi.org/10.1097/PAI.0000000000000875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132912/
https://www.ncbi.nlm.nih.gov/pubmed/33031101
http://dx.doi.org/10.1097/PAI.0000000000000875

Ejemplares similares